Kidney Cancer News and Research

RSS

Kidney cancer is usually defined is a cancer that originates in the kidney. The two most common types of kidney cancer, reflecting their location within the kidney, are renal cell carcinoma (RCC) and urothelial cell carcinoma (UCC) of the renal pelvis.

Transplant patients experience worse outcomes from cancer

After comparing two patient cancer registries - one featuring transplant patients and the other the general population - researchers at the University of Cincinnati (UC) have found that transplant patients experience worse outcomes from cancer.

17 May 2009

Full kidney removal is not always the best treatment for small renal tumors

Nephron-sparing treatments, such as partial nephrectomy, thermal ablation and active surveillance, minimize these risks and are viable options for patients with early-stage (T1a) kidney tumors, according to a new clinical guideline issued by the American Urological Association (AUA).

30 Apr 2009

Finding will improve accuracy of cancer diagnosis

Van Andel Research Institute (VARI) investigators working in collaboration with Cleveland Clinic researchers have determined that two types of kidney tumors previously thought to be different diseases are actually variations of the same disease.

29 Apr 2009

Kidney reconstruction performed though single incision hidden in the navel

With a single incision hidden in the navel, surgeons at the University of California, San Diego Medical Center have successfully removed a cancerous kidney tumor while saving the patient's kidney.

9 Apr 2009

Molecular test for cancer relapse in UK children

A molecular marker used in America to predict whether children with a form of kidney cancer, called Wilms' tumour, are more likely to relapse than other children, could be useful for UK patients.

2 Apr 2009

FDA approves Afinitor oral tablets (everolimus) for advanced form of kidney cancer

The U.S. Food and Drug Administration today approved Afinitor oral tablets (everolimus) for the treatment of patients with advanced kidney cancer whose disease has progressed after treatment with other cancer therapies.

30 Mar 2009

Discovery of new cancer gene

Researchers have identified a new cancer gene - one that is common to many cancers and affects the most basic regulation of our genes.

29 Mar 2009

New therapeutic approaches to castrate resistant prostate cancer

Today Dr. Martin Gleave of the Vancouver Prostate Centre in Canada gave a lecture about new approaches to treat castrate-resistant prostate cancer (CRCP) during the 24 th Annual Congress of the European Association of Urology in Stockholm, Sweden.

22 Mar 2009

The navel shown to be a safe and effective single access route for extracting kidneys

Successful surgery that leaves no scars has become the main objective of the most daring and innovative surgeons.

From Evident Corporation - Life Sciences 12 Mar 2009

Freezing kidney cancer - interventional cryoablation

Freezing kidney tumors - using a safe minimally invasive interventional radiology treatment that kills the cancer 100 percent effectively without surgery - should be the gold standard or first treatment option for all individuals with tumors that are 4 centimeters in size or smaller.

10 Mar 2009

Molecular test for cancer relapse in UK children

A molecular marker used in America to predict whether children with a form of kidney cancer, called Wilms' tumour, are more likely to relapse than other children, could be useful for UK patients.

3 Mar 2009

New cancer treatment stops aggressive sarcomas

After all standard treatments had failed, a new cancer treatment has stopped the growth of aggressive sarcomas in two recent patients. These results are similar to the new protocol's previous success against several cancers, including melanoma, pancreatic, colon, mesothelioma and other sarcomas.

25 Feb 2009

New trial targets kidney cancer drug sorafenib in bladder cancer

According to the American Cancer Society, 69,000 cases of bladder cancer were diagnosed nationwide last year with some 2,600 new cases in New Jersey.

16 Feb 2009

UK kidney cancer patients face toxic, out-dated treatments with little hope of change

Leading oncologist Professor Tim Eisen has expressed concerns that patients with advanced kidney cancer could be condemned to toxic, barely effective, 20 year-old treatments because the National Institute for Health and Clinical Excellence (NICE) is likely to rule out using all four of the new treatments it has assessed.

10 Dec 2008

Overweight children may inherit faster eating behaviour

Overweight children may inherit faster eating behaviour according to a Cancer Research UK study published in the American Journal of Clinical Nutrition.

10 Dec 2008

Scientists pinpoint two new risk factors for Wilms tumour

Scientists at The Institute of Cancer Research have made significant progress in pinpointing two new risk factors associated with the most common childhood kidney cancer, known as Wilms tumour.

1 Dec 2008

Variations within three genes associated with lipid peroxidation could increase kidney cancer risk

A team of international scientists has identified three genes associated with the body's processing of fats that may increase susceptibility to kidney cancer.

17 Nov 2008

Research suggests doctors should consider kidney-sparing surgery

A study of almost 1,500 kidney cancer patients treated at Memorial Sloan Kettering Cancer Center suggests that surgery to spare as much kidney tissue as possible may improve overall survival in patients who also have reduced kidney function at the time their cancer is diagnosed. The finding is significant because both kidney cancer and decreased kidney function appear to be increasing.

2 Oct 2008

Antisoma commences phase II trial of AS1411 in metastatic renal cell carcinoma

Cancer drug developer Antisoma plc today announced that it has started a phase II study of AS1411 in metastatic renal cell carcinoma (kidney cancer).

4 Sep 2008

Urologist is first in the world to use robot-assisted surgery to repair rare defect

A urologist at Wake Forest University Baptist Medical Center is the first in the world to repair a rare type of hernia using robot-assisted, minimally invasive surgery. The surgery required only an 18-hour hospital stay; typically, the repair involves major surgery and three to five days of hospital care.

31 Aug 2008